Abstract
This is in reference to the letter to the editor entitled ‘Mucormycosis and Black fungus: Breaking the myth’ in response to the published editorial “Mucormycosis – An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19.” First of all, the editorial was written clearly to reach out to a large audience of non-specialists and especially mucormycosis cases associated with COVID-19 in India. The work was drafted considering the current pandemic, where mucormycosis surfaced as a post-COVID-19 complication and often referred to as the so-called black fungus not only by the media but also by many peer-reviewed journals [1–10].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
